Furthermore, TMX markedly enhanced the efficacy of TRA-8 therapy on tumorigenesis of the resistant PANC-1 pancreatic cancer cells in vivo, which was associated with increased expression of DR-5 and increased activation of the caspase-8. The gene discussed is TNFRSF10B; the disease is familial pancreatic carcinoma.